IL‐10 producing type 2 innate lymphoid cells prolong islet allograft survival

Type 2 innate lymphoid cells (ILC2s) are a subset of ILCs with critical roles in immunoregulation. However, the possible role of ILC2s as immunotherapy against allograft rejection remains unclear. Here, we show that IL‐33 significantly prolonged islet allograft survival. IL‐33‐treated mice had eleva...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Qingsong, Ma, Xiaoqian, Wang, Yiping, Niu, Zhiguo, Wang, Ruifeng, Yang, Fuyan, Wu, Menglin, Liang, Guining, Rong, Pengfei, Wang, Hui, Harris, David CH, Wang, Wei, Cao, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645373/
https://www.ncbi.nlm.nih.gov/pubmed/33034128
http://dx.doi.org/10.15252/emmm.202012305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645373/
https://www.ncbi.nlm.nih.gov/pubmed/33034128
http://dx.doi.org/10.15252/emmm.202012305

Ejemplares similares